Reaction
Tonsillectomy reporting signals
As of the last recalculation, Tonsillectomy appears in 1,650 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 46.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 302 | 46.0 | 46.1 |
| Etonogestrel And Ethinyl Estradiol | 64 | 37.8 | 37.9 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 12 | 17.7 | 17.7 |
| Nicotine Polacrilex Mini | 19 | 16.1 | 16.2 |
| Nicotine Polarilex | 19 | 16.1 | 16.2 |
| Sodium Oxybate | 75 | 15.0 | 15.0 |
| Ivacaftor | 9 | 14.4 | 14.4 |
| Armodafinil | 20 | 12.1 | 12.1 |
| Lumacaftor And Ivacaftor | 8 | 11.8 | 11.8 |
| Sitagliptin | 56 | 10.1 | 10.1 |
| Sitagliptin And Metformin Hydrochloride | 17 | 10.0 | 10.0 |
| Finasteride | 45 | 9.6 | 9.7 |
| Risankizumab-Rzaa | 56 | 8.9 | 8.9 |
| Modafinil | 22 | 8.7 | 8.7 |
| Vigabatrin | 9 | 7.8 | 7.8 |
| Dornase Alfa | 11 | 7.1 | 7.1 |
| Upadacitinib | 41 | 6.5 | 6.5 |
| Atomoxetine Hydrochloride | 12 | 6.4 | 6.4 |
| Nicotine Polacrilex | 19 | 6.3 | 6.3 |
| Nicotine | 20 | 6.3 | 6.3 |
| Pancrelipase | 19 | 6.3 | 6.3 |
| Isotretinoin | 18 | 4.6 | 4.6 |
| Voxelotor | 8 | 4.5 | 4.5 |
| Bimekizumab | 7 | 4.2 | 4.2 |
| Emicizumab | 4 | 4.1 | 4.1 |
| Cannabidiol | 7 | 3.8 | 3.8 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 3.8 | 3.8 |
| Ixekizumab | 9 | 3.1 | 3.1 |
| Somatropin | 16 | 2.8 | 2.8 |